ArkeaBio Raises $15M for Methane Vaccine

ArkeaBio raised $15 million to advance its methane-reducing livestock vaccine.

What happened

The company is developing a vaccine approach designed to reduce methane emissions from livestock. The new capital supports continued development as the company works toward commercial and scientific milestones.

Livestock methane is a major agricultural emissions problem, and reducing it has become an important target for climate-focused food and agriculture technologies.

Why it matters

Many methane-reduction approaches rely on feed additives or farm-management changes, which can be difficult to apply consistently across herds and regions. A vaccine could be more scalable if it proves safe, effective and commercially practical.

The science still needs validation, but the category is important because agriculture needs emissions solutions that work in real farm conditions.

The bigger picture

Climate tech is moving deeper into biology and agriculture. The hardest emissions problems will likely require a mix of software, hardware, chemistry and biotech, not only renewable energy deployment.